SUBSCRIBE
SUBSCRIBE

Neuropsychiatric disorders

Drug Development
Deep Dive: Psychedelics for Mental Health
In this deep dive BioSpace analyzes the neuropsychedelic therapeutics pipeline, which grabbed headlines in February when the FDA accepted the New Drug Application for Lykos Therapeutics’ MDMA capsules for PTSD.
June 5, 2024
 · 
4 min read
 · 
Heather McKenzie
Load More
PRESS RELEASES
Press Releases
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2025
May 15, 2025
 · 
10 min read
Press Releases
Second Generation Antipsychotics Market to Hit USD 15.67 Bn by 2032, at a CAGR of 6.25%, says Coherent Market Insights
May 13, 2025
 · 
1 min read
Press Releases
CaaMTech Spins Out Transneural Therapeutics to Develop Novel Neuroplastogens
April 23, 2025
 · 
3 min read
Press Releases
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2024
March 25, 2025
 · 
13 min read
Press Releases
Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024
October 31, 2024
 · 
7 min read
Press Releases
Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA™ Technology
October 17, 2024
 · 
8 min read